New Key Statistics Module, Z-Score and F-Score
OTCPK:RPHCF Key Ratios
Market Cap $ M | 4,273.18 |
Enterprise Value $ M | 4,218.56 |
P/E(ttm) | 24.80 |
PE Ratio without NRI | 24.14 |
Forward PE Ratio | 20.98 |
Price/Book | 2.66 |
Price/Sales | 2.40 |
Price/Free Cash Flow | 26.69 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,901.00 |
EPS (TTM) $ | 0.80 |
Beneish M-Score | -2.39 |
10-y EBITDA Growth Rate % | 9.50 |
5-y EBITDA Growth Rate % | 16.30 |
y-y EBITDA Growth Rate % | 7.50 |
EV-to-EBIT | 17.62 |
EV-to-EBITDA | 15.77 |
PEG | 1.48 |
Shares Outstanding M | 228.14 |
Net Margin (%) | 9.67 |
Operating Margin % | 13.07 |
Pre-tax Margin (%) | 13.31 |
Quick Ratio | 1.29 |
Current Ratio | 1.84 |
ROA % (ttm) | 7.62 |
ROE % (ttm) | 11.22 |
ROIC % (ttm) | 10.55 |
Dividend Yield % | -- |
Altman Z-Score | 4.82 |
RPHCF Number of Guru Trades
RPHCF Volume of Guru Trades
Gurus Latest Trades with OTCPK:RPHCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RPHCF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Rohto Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:RPHCF
Total 0- 1